AU2001292617A1 - Mammalian receptor genes and uses - Google Patents

Mammalian receptor genes and uses

Info

Publication number
AU2001292617A1
AU2001292617A1 AU2001292617A AU9261701A AU2001292617A1 AU 2001292617 A1 AU2001292617 A1 AU 2001292617A1 AU 2001292617 A AU2001292617 A AU 2001292617A AU 9261701 A AU9261701 A AU 9261701A AU 2001292617 A1 AU2001292617 A1 AU 2001292617A1
Authority
AU
Australia
Prior art keywords
receptor genes
mammalian receptor
mammalian
genes
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292617A
Inventor
James R. Bunzow
David K. Grandy
Mark Sonders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/659,519 external-priority patent/US6783973B1/en
Application filed by Oregon Health Science University filed Critical Oregon Health Science University
Publication of AU2001292617A1 publication Critical patent/AU2001292617A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001292617A 2000-09-12 2001-09-12 Mammalian receptor genes and uses Abandoned AU2001292617A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/659,519 2000-09-12
US09/659,519 US6783973B1 (en) 2000-09-12 2000-09-12 Mammalian catecholamine receptor genes and uses
US30396701P 2001-07-09 2001-07-09
US60/303,967 2001-07-09
PCT/US2001/028455 WO2002022801A2 (en) 2000-09-12 2001-09-12 Mammalian receptor genes and uses

Publications (1)

Publication Number Publication Date
AU2001292617A1 true AU2001292617A1 (en) 2002-03-26

Family

ID=26973745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292617A Abandoned AU2001292617A1 (en) 2000-09-12 2001-09-12 Mammalian receptor genes and uses

Country Status (4)

Country Link
EP (1) EP1319070A2 (en)
AU (1) AU2001292617A1 (en)
CA (1) CA2422288A1 (en)
WO (1) WO2002022801A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083851A2 (en) * 2003-03-18 2004-09-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1)
EP1621552A1 (en) * 2004-07-08 2006-02-01 F.Hoffmann-La Roche Ag Human trace amine associated receptors (hTAAR)
EP1626057A1 (en) * 2004-07-30 2006-02-15 F.Hoffmann-La Roche Ag Chimpanzee trace amine associated receptors
US7368541B2 (en) 2004-12-01 2008-05-06 Merck & Co., Inc. Trace amine receptor 1 of the African green monkey
WO2007085558A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of cns disorders
RU2008130455A (en) 2006-01-27 2010-03-10 Ф.Хоффманн-Ля Рош Аг (Ch) USE OF SUBSTITUTED 2-IMIDAZOLE DERIVATIVES OR IMIDAZOLINES
JP2009524619A (en) * 2006-01-27 2009-07-02 エフ．ホフマン−ラ ロシュ アーゲー Use of 2-imidazole for the treatment of CNS disorders
CN101528710B (en) 2006-10-19 2012-11-07 弗·哈夫曼-拉罗切有限公司 Aminomethyl-4-imidazoles
EP2086959B1 (en) 2006-11-02 2011-11-16 F. Hoffmann-La Roche AG Substituted 2-imidazoles as modulators of the trace amine associated receptors
CN101535298A (en) 2006-11-16 2009-09-16 弗·哈夫曼-拉罗切有限公司 Substituted 4-imidazoles
CN101557810B (en) 2006-12-13 2012-11-21 弗·哈夫曼-拉罗切有限公司 Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
UA98951C2 (en) 2007-02-02 2012-07-10 Ф. Хоффманн-Ля Рош Аг 2-aminooxazolines and medicament comprising thereof
KR101222412B1 (en) 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 2-aminooxazolines as taar1 ligands
AU2008270445A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (TAARs)
WO2009003867A1 (en) 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
CA2694362A1 (en) 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
JP5341084B2 (en) 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
MY195528A (en) 2016-03-17 2023-01-30 Hoffmann La Roche 5-Ethyl-4-Methyl-Pyrazole-3-Carboxamide Derivative Having Activity as Agonist of Taar

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277591B1 (en) * 1988-11-18 2001-08-21 Oregon Health Science University Dopamine receptors and genes
US5871967A (en) * 1997-01-24 1999-02-16 Smithkline Beecham Corporation Cloning of a novel G-Protein coupled 7TM receptor
AU5168700A (en) * 1999-05-28 2000-12-18 Synaptic Pharmaceutical Corporation Dna encoding snorf33 receptor
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
US6890731B1 (en) * 2000-03-27 2005-05-10 Applera Corporation Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof

Also Published As

Publication number Publication date
WO2002022801A9 (en) 2003-07-03
EP1319070A2 (en) 2003-06-18
CA2422288A1 (en) 2002-03-21
WO2002022801A3 (en) 2003-03-06
WO2002022801A2 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2001292617A1 (en) Mammalian receptor genes and uses
AU2002210295A1 (en) Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof
AU2002225756A1 (en) Uses of mammalian genes and related reagents
EP1130098A3 (en) Mammalian osteoregulins
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2002314433A1 (en) Ephrin-tie receptor materials and methods
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU5898800A (en) Atherosclerosis-associated genes
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU2088801A (en) Metastasis genes and uses thereof
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2001293074A1 (en) Human liver cell line
AU2001240103A1 (en) Reproduction-specific genes
AU7039400A (en) Solid soap with connecting and keeping means
AU2376200A (en) Insulin-synthesis genes
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU2001288985A1 (en) Uses of mammalian genes and related reagents
AU1894601A (en) Novel gene and use thereof
AU3244801A (en) Modified DHPS genes
AU6878200A (en) Novel receptors and genes encoding the same
AU2001223882A1 (en) Receptor
AUPQ563400A0 (en) Novel receptor
AU1604701A (en) Mammalian genes; related reagents and methods
AU2001280891A1 (en) Uses of mammalian genes and related reagents
AU7024500A (en) Essential genes and assays relating thereto